Henry Schein, Inc. announced leadership transitions effective October 30, 2026, when Executive Vice President and Chief Operating Officer Michael S. Ettinger, Executive Vice President and Chief Strategic Officer Mark E. Mlotek, and Senior Vice President James Mullins will transition from their current roles into senior advisory positions. The company is simultaneously restructuring its governance by creating the Henry Schein Leadership Team to replace the Executive Management Committee and integrating its global supply chain organization with its distribution group. These executives are entitled to payments under the Company’s Executive Severance Plan. This organizational change aims to simplify the operating model, accelerate decision-making, and enhance customer-centricity within the healthcare products and services industry.
